Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A Aberg

Showing results (41-50 of 211) with videos related to

Pageof 22
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 25, 2014
Differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursorsFrances Mercer, Alka Khaitan, Lina Kozhaya, et al.
ISRN Gastroenterology|October 13, 2011
Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected PatientsChristian A Engell, Vinh Philip Pham, Robert S Holzman, et al.
Journal of Clinical Lipidology|September 9, 2010
Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087Carl J Fichtenbaum, Tzu-Min Yeh, Scott R Evans, et al.
Journal of Clinical Gastroenterology|May 7, 2004
Cure of acute hepatitis C in HIV co-infection?Maria B Ristig, Pablo Tebas, Iver Gandy, et al.
Antiviral Therapy|May 22, 2023
The evolution of clinical study design in heavily treatment-experienced persons with HIV: A critical reviewJudith A Aberg, Anthony Mills, Santiago Moreno, et al.
The Journal of Infectious Diseases|August 21, 2019
The Science and Value of Diversity: Closing the Gaps in Our Understanding of Inclusion and DiversityTalia H Swartz, Ann-Gel S Palermo, Sandra K Masur, et al.
Journal of Clinical Lipidology|April 11, 2017
JCL roundtable: Managing lipid disorders in patients with HIVW Virgil Brown, Judith A Aberg, Karen E Aspry, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 10, 2014
Lack of pharmacokinetic interactions between pitavastatin and efavirenz or darunavir/ritonavirCarlos D Malvestutto, Qing Ma, Gene D Morse, et al.
AIDS Patient Care and Stds|February 14, 2012
Glycated Hemoglobin A(1c) as screening for diabetes mellitus in HIV-infected individualsBenjamin J Eckhardt, Robert S Holzman, Candice K Kwan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2003
Nonnucleoside reverse transcriptase inhibitor resistance among antiretroviral-naive HIV-positive pregnant womenSalome N Juethner, Catherine Williamson, Maria B Ristig, et al.
Pageof 22

Showing results (41-50 of 211) with videos related to

Sort By:
Pageof 22
Journal of Immunology (Baltimore, Md. : 1950)|June 25, 2014
Differentiation of IL-17-producing effector and regulatory human T cells from lineage-committed naive precursorsFrances Mercer, Alka Khaitan, Lina Kozhaya, et al.
ISRN Gastroenterology|October 13, 2011
Virologic Outcome of Using Tenofovir/Emtricitabine to Treat Hepatitis B in HIV-Coinfected PatientsChristian A Engell, Vinh Philip Pham, Robert S Holzman, et al.
Journal of Clinical Lipidology|September 9, 2010
Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087Carl J Fichtenbaum, Tzu-Min Yeh, Scott R Evans, et al.
Journal of Clinical Gastroenterology|May 7, 2004
Cure of acute hepatitis C in HIV co-infection?Maria B Ristig, Pablo Tebas, Iver Gandy, et al.
Antiviral Therapy|May 22, 2023
The evolution of clinical study design in heavily treatment-experienced persons with HIV: A critical reviewJudith A Aberg, Anthony Mills, Santiago Moreno, et al.
The Journal of Infectious Diseases|August 21, 2019
The Science and Value of Diversity: Closing the Gaps in Our Understanding of Inclusion and DiversityTalia H Swartz, Ann-Gel S Palermo, Sandra K Masur, et al.
Journal of Clinical Lipidology|April 11, 2017
JCL roundtable: Managing lipid disorders in patients with HIVW Virgil Brown, Judith A Aberg, Karen E Aspry, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 10, 2014
Lack of pharmacokinetic interactions between pitavastatin and efavirenz or darunavir/ritonavirCarlos D Malvestutto, Qing Ma, Gene D Morse, et al.
AIDS Patient Care and Stds|February 14, 2012
Glycated Hemoglobin A(1c) as screening for diabetes mellitus in HIV-infected individualsBenjamin J Eckhardt, Robert S Holzman, Candice K Kwan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 7, 2003
Nonnucleoside reverse transcriptase inhibitor resistance among antiretroviral-naive HIV-positive pregnant womenSalome N Juethner, Catherine Williamson, Maria B Ristig, et al.
Pageof 22